Tech Company Financing Transactions
Nevakar Funding Round
Nevakar, operating out of Bridgewater, raised $20 million from Oxford Finance.
Transaction Overview
Company Name
Announced On
12/3/2018
Transaction Type
Debt
Amount
$20,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from the financings will be used to accelerate the company's pipeline projects and for general corporate services.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1019 US Hwy. Building K NJ Center of Excellence 202-206
Bridgewater, NJ 08807
USA
Bridgewater, NJ 08807
USA
Phone
Website
Email Address
Overview
Nevakar is a specialty pharmaceutical company focused on developing innovative ophthalmic and injectable products. Our goal is to create value for the healthcare system by offering products that are accessible and lead to better outcomes for patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Navneet Puri
Chief Financial Officer
Marshall Woodworth
Chief Operating Officer
Sriram Ramanathan
Chief Scientific Officer
Kumaresh Soppimath
Vice President
Jon Cammack
VP - Bus. Development
Raul Trillo
Browse more venture capital transactions:
Prev: 12/3/2018: Myia venture capital transaction
Next: 12/3/2018: Fetch Rewards venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs